Charles Zhu
Stock Analyst at LifeSci Capital
(2.22)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CBIO Crescent Biopharma | Initiates Coverage On: Outperform | 22 | 12.96 | 69.75% | 1 | Jun 18, 2025 | |
RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
TNGX Tango Therapeutics | Maintains: Buy | 18 8 | 6.42 | 24.61% | 3 | Nov 7, 2024 | |
MGNX Macrogenics | Upgrades: Buy | 12 | 1.47 | 716.33% | 4 | Nov 7, 2023 | |
MRUS Merus | Maintains: Strong Buy | 46 48 | 64.6 | -25.7% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 56 | 74.98 | -25.31% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 3.09 | 611.97% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 10.93 | 137.88% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 22.84 | 40.11% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 12.5 | 60% | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 12.45 | 12.45% | 2 | May 5, 2022 |